Search research articles
Contact Us
Filters
Showing results (381-390 of 391) with videos related to
Page
of 40
Sort By:
Neurology
|
January 26, 2021
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease
Nelly Joseph-Mathurin, Guoqiao Wang, Kejal Kantarci, et al.
Nature Neuroscience
|
July 10, 2023
Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)
Nicole S McKay, Brian A Gordon, Russ C Hornbeck, et al.
Molecular Psychiatry
|
March 23, 2019
The BDNF<sub>Val66Met</sub> SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease
Nicolai Franzmeier, Jinyi Ren, Alexander Damm, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 21, 2024
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
Nelly Joseph-Mathurin, Rebecca L Feldman, Ruijin Lu, et al.
The Lancet. Neurology
|
March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Randall J Bateman, Yan Li, Eric M McDade, et al.
Nature Medicine
|
June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Stephen Salloway, Martin Farlow, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial
Randall J Bateman, Yan Li, Eric M McDade, et al.
Nature Medicine
|
June 18, 2024
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Madhurima Chatterjee, Selcuk Özdemir, Christian Fritz, et al.
Journal of Alzheimer'S Disease : JAD
|
November 14, 2025
Associations of lifestyle factors with amyloid pathology in persons without dementia
Julie E Oomens, Stephanie Jb Vos, Nancy N Maserejian, et al.
JAMA Psychiatry
|
January 22, 2025
Depressive Symptoms and Amyloid Pathology
Wietse A Wiels, Julie E Oomens, Sebastiaan Engelborghs, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 391) with videos related to
Sort By:
Page
of 40
Neurology
|
January 26, 2021
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease
Nelly Joseph-Mathurin, Guoqiao Wang, Kejal Kantarci, et al.
Nature Neuroscience
|
July 10, 2023
Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)
Nicole S McKay, Brian A Gordon, Russ C Hornbeck, et al.
Molecular Psychiatry
|
March 23, 2019
The BDNF<sub>Val66Met</sub> SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease
Nicolai Franzmeier, Jinyi Ren, Alexander Damm, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 21, 2024
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
Nelly Joseph-Mathurin, Rebecca L Feldman, Ruijin Lu, et al.
The Lancet. Neurology
|
March 22, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
Randall J Bateman, Yan Li, Eric M McDade, et al.
Nature Medicine
|
June 22, 2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Stephen Salloway, Martin Farlow, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial
Randall J Bateman, Yan Li, Eric M McDade, et al.
Nature Medicine
|
June 18, 2024
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
Madhurima Chatterjee, Selcuk Özdemir, Christian Fritz, et al.
Journal of Alzheimer'S Disease : JAD
|
November 14, 2025
Associations of lifestyle factors with amyloid pathology in persons without dementia
Julie E Oomens, Stephanie Jb Vos, Nancy N Maserejian, et al.
JAMA Psychiatry
|
January 22, 2025
Depressive Symptoms and Amyloid Pathology
Wietse A Wiels, Julie E Oomens, Sebastiaan Engelborghs, et al.
Page
of 40